PL424191A1 - Mucoadhesive oral preparation with the extract from Cannabis (Cannabis sativa) and method for producing it - Google Patents
Mucoadhesive oral preparation with the extract from Cannabis (Cannabis sativa) and method for producing itInfo
- Publication number
- PL424191A1 PL424191A1 PL424191A PL42419118A PL424191A1 PL 424191 A1 PL424191 A1 PL 424191A1 PL 424191 A PL424191 A PL 424191A PL 42419118 A PL42419118 A PL 42419118A PL 424191 A1 PL424191 A1 PL 424191A1
- Authority
- PL
- Poland
- Prior art keywords
- cannabis
- extract
- producing
- amount
- mucoadhesive
- Prior art date
Links
- 230000003232 mucoadhesive effect Effects 0.000 title abstract 4
- 244000025254 Cannabis sativa Species 0.000 title abstract 2
- 241000218236 Cannabis Species 0.000 title 1
- 235000008697 Cannabis sativa Nutrition 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
- 238000009472 formulation Methods 0.000 abstract 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- WLAMNBDJUVNPJU-UHFFFAOYSA-N 2-methylbutyric acid Chemical compound CCC(C)C(O)=O WLAMNBDJUVNPJU-UHFFFAOYSA-N 0.000 abstract 1
- 235000012766 Cannabis sativa ssp. sativa var. sativa Nutrition 0.000 abstract 1
- 235000012765 Cannabis sativa ssp. sativa var. spontanea Nutrition 0.000 abstract 1
- 102000014171 Milk Proteins Human genes 0.000 abstract 1
- 108010011756 Milk Proteins Proteins 0.000 abstract 1
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 abstract 1
- 229920000148 Polycarbophil calcium Polymers 0.000 abstract 1
- 229920003081 Povidone K 30 Polymers 0.000 abstract 1
- 235000009120 camo Nutrition 0.000 abstract 1
- 235000005607 chanvre indien Nutrition 0.000 abstract 1
- 239000012141 concentrate Substances 0.000 abstract 1
- 239000011487 hemp Substances 0.000 abstract 1
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 abstract 1
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 abstract 1
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 abstract 1
- 229960003943 hypromellose Drugs 0.000 abstract 1
- 239000000314 lubricant Substances 0.000 abstract 1
- 235000019359 magnesium stearate Nutrition 0.000 abstract 1
- 239000011159 matrix material Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 235000021239 milk protein Nutrition 0.000 abstract 1
- 239000000546 pharmaceutical excipient Substances 0.000 abstract 1
- 229950005134 polycarbophil Drugs 0.000 abstract 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 abstract 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 abstract 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 abstract 1
- 239000000230 xanthan gum Substances 0.000 abstract 1
- 235000010493 xanthan gum Nutrition 0.000 abstract 1
- 229920001285 xanthan gum Polymers 0.000 abstract 1
- 229940082509 xanthan gum Drugs 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
Przedmiotem zgłoszenia jest mukoadhezyjny preparat, który charakteryzuje się tym, że zawiera wyciąg z konopi siewnej, aserosil zmieszany z wyciągiem w stosunku 1:1 lub 1:2, matrycę o charakterze mukoadhezyjnym, zawierającą Carbopol 974P lub hypromelozę (typ 2208) lub koncentrat białek mleka (Carbelac 80) lub gumę ksantanową lub polikarbofil (Noveon AA-1) lub poliwinylopirolidon (PVP K30 i K90) - w ilości od 2 do 40%. Ponadto, preparat według wynalazku zawiera substancje pomocnicze - w ilości od 10 do 60% i substancję poślizgową: stearynian magnezu - w ilości od 1 do 1,5%. Zgłoszenie to obejmuje też sposób wytwarzania mukuadhezyjnego preparatu.The subject of the application is a mucoadhesive preparation, which is characterized by containing hemp extract, aserosil mixed with the extract in a ratio of 1: 1 or 1: 2, a mucoadhesive matrix containing Carbopol 974P or hypromellose (type 2208) or milk protein concentrate (Carbelac 80) or xanthan gum or polycarbophil (Noveon AA-1) or polyvinylpyrrolidone (PVP K30 and K90) - in an amount of 2 to 40%. In addition, the formulation according to the invention contains excipients in an amount of 10 to 60% and a lubricant: magnesium stearate in an amount of 1 to 1.5%. This application also includes a method of producing a muco-adhesive formulation.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PL424191A PL424191A1 (en) | 2018-01-04 | 2018-01-04 | Mucoadhesive oral preparation with the extract from Cannabis (Cannabis sativa) and method for producing it |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PL424191A PL424191A1 (en) | 2018-01-04 | 2018-01-04 | Mucoadhesive oral preparation with the extract from Cannabis (Cannabis sativa) and method for producing it |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL424191A1 true PL424191A1 (en) | 2019-07-15 |
Family
ID=67209624
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL424191A PL424191A1 (en) | 2018-01-04 | 2018-01-04 | Mucoadhesive oral preparation with the extract from Cannabis (Cannabis sativa) and method for producing it |
Country Status (1)
| Country | Link |
|---|---|
| PL (1) | PL424191A1 (en) |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101351495A (en) * | 2005-12-29 | 2009-01-21 | 欧加农股份有限公司 | fatty acid amide hydrolase inhibitors |
| US20160051510A1 (en) * | 2014-07-28 | 2016-02-25 | Eric Allen | Oral dissolvable film that includes plant extract |
| WO2017180707A1 (en) * | 2016-04-12 | 2017-10-19 | Schaneville Scott | Ingestible films having substances from hemp or cannabis |
-
2018
- 2018-01-04 PL PL424191A patent/PL424191A1/en unknown
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101351495A (en) * | 2005-12-29 | 2009-01-21 | 欧加农股份有限公司 | fatty acid amide hydrolase inhibitors |
| US20160051510A1 (en) * | 2014-07-28 | 2016-02-25 | Eric Allen | Oral dissolvable film that includes plant extract |
| WO2017180707A1 (en) * | 2016-04-12 | 2017-10-19 | Schaneville Scott | Ingestible films having substances from hemp or cannabis |
Non-Patent Citations (1)
| Title |
|---|
| CANABIDOL, CANABIDOL KAPSUŁKI ZAWIERAJĄCE 300 MG CBD HYPROMELOZĘ 1 3 8 Y STEARYNIAN MAGNEZU ORAZ ŻEL BEZ OTOCZKI 1000 MG FIRMY CANABIDOL * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1216319A1 (en) | Anhydrous hydrogel composition | |
| MX344787B (en) | Compositions containing berberine or analogs thereof for treating rosacea or red face related skin disorders. | |
| DE502005008880D1 (en) | LIPOSOMAL COMPOSITION CONTAINING AN ACTIVE SUBSTANCE FOR RELAXING SMOOTH MUSCULATURE, THE PREPARATION OF THIS COMPOSITION, AND THEIR THERAPEUTIC USE | |
| PE20070216A1 (en) | NEW PHARMACEUTICAL COMPOSITIONS INCLUDING LEVETIRACETAM AND PROCESS FOR ITS PREPARATION | |
| MX361372B (en) | Orally available pharmaceutical formulation suitable for improved management of movement disorders. | |
| PH12020500204A1 (en) | Compounds and pharmaceutical compositions thereof for use in the treatment of fibrotic disease | |
| PL424191A1 (en) | Mucoadhesive oral preparation with the extract from Cannabis (Cannabis sativa) and method for producing it | |
| PE20220942A1 (en) | COMPOSITION OF A SMALL-MOLECULE PI4KIIIalpha INHIBITOR, METHOD OF PREPARATION AND APPLICATION OF THE SAME | |
| EA201892688A1 (en) | ANTIMICROBIAL COMPOSITIONS FOR LOCAL APPLICATION | |
| EA202090827A1 (en) | Oral Compositions for the Treatment of Gastroesophageal Reflux | |
| EA201790974A1 (en) | FRESHENER FOR ORAL CAVITY | |
| BR112022021012A2 (en) | BITTER TASTE BLOCKERS AND RELATED METHODS OF USE | |
| PE20220381A1 (en) | VAGINAL TABLET FORMULATION | |
| HK1252549A1 (en) | Controlled-release tozadenant formulations | |
| BR0317654A (en) | Compositions for oral administration of active ingredients requiring taste masking | |
| WO2018069805A3 (en) | Method for preparation of liquid oral composition of l-thyroxin | |
| MX2018013781A (en) | Composition and method of manufacturing calcium sulfonate and calcium magnesium sulfonate greases using a delay after addition of facilitating acid. | |
| MX2021004553A (en) | Pharmaceutical compositions and methods of making on demand solid dosage formulations. | |
| EA202193285A1 (en) | COMPOSITION WITH MODIFIED RELEASE PYRIMIDINYLAMINOPYRAZOLE COMPOUND AND METHODS OF TREATMENT | |
| LIN | Developing a Megalopolis of the Future | |
| PL420036A1 (en) | Composition for preventing and fighting bee diseases and the application of hemp oil for obtaining of the composition | |
| MA46358B1 (en) | Pharmaceutical compositions of 5-ht6 antagonist | |
| SG11201908629WA (en) | Anti-inflammatory agent | |
| PL416198A1 (en) | Pharmaceutical composition containing combination of hyaluronic acid and plant phytoestrogens for vaginal application | |
| WO2024020361A3 (en) | Inhalable serotonin receptor agonist formulations |